UBS Asset Management Americas Inc. cut its stake in shares of athenahealth, Inc (NASDAQ:ATHN) by 11.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 29,009 shares of the health services provider’s stock after selling 3,591 shares during the quarter. UBS Asset Management Americas Inc. owned approximately 0.07% of athenahealth worth $3,859,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Perceptive Advisors LLC bought a new position in shares of athenahealth during the third quarter valued at $8,705,000. Sei Investments Co. lifted its holdings in shares of athenahealth by 36.6% during the third quarter. Sei Investments Co. now owns 128,190 shares of the health services provider’s stock valued at $15,942,000 after acquiring an additional 34,332 shares during the period. SG Americas Securities LLC bought a new position in shares of athenahealth during the third quarter valued at $485,000. Toronto Dominion Bank lifted its holdings in shares of athenahealth by 38.6% during the fourth quarter. Toronto Dominion Bank now owns 305,000 shares of the health services provider’s stock valued at $40,577,000 after acquiring an additional 85,000 shares during the period. Finally, Trexquant Investment LP bought a new position in shares of athenahealth during the third quarter valued at $727,000.
A number of research analysts recently issued reports on ATHN shares. Royal Bank of Canada reaffirmed a “hold” rating and issued a $152.00 price target on shares of athenahealth in a report on Friday, February 2nd. BidaskClub cut athenahealth from a “sell” rating to a “strong sell” rating in a report on Saturday, February 3rd. Bank of America started coverage on athenahealth in a report on Tuesday, February 27th. They issued a “neutral” rating and a $147.00 price target for the company. SunTrust Banks lifted their price target on athenahealth to $180.00 and gave the company a “buy” rating in a report on Monday, February 5th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and issued a $160.00 price target on shares of athenahealth in a report on Friday, February 16th. Three equities research analysts have rated the stock with a sell rating, seventeen have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $144.35.
Shares of athenahealth, Inc (ATHN) opened at $146.01 on Wednesday. The firm has a market capitalization of $5,977.38, a PE ratio of 88.21, a price-to-earnings-growth ratio of 2.58 and a beta of 1.17. athenahealth, Inc has a twelve month low of $95.01 and a twelve month high of $158.66. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32.
athenahealth (NASDAQ:ATHN) last posted its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.48. The company had revenue of $329.20 million during the quarter, compared to analyst estimates of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The company’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.62 EPS. equities analysts anticipate that athenahealth, Inc will post 2.69 earnings per share for the current fiscal year.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.